BNP Paribas Financial Markets’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $631M | Sell |
|
|||||
|
2025
Q1 | $819M | Sell |
|
|||||
|
2024
Q4 | $1.07B | Buy |
|
|||||
|
2024
Q3 | $297M | Sell |
|
|||||
|
2024
Q2 | $490M | Buy |
|
|||||
|
2024
Q1 | $347M | Buy |
|
|||||
|
2023
Q4 | $62.7M | Sell |
|
|||||
|
2023
Q3 | $213M | Buy |
|
|||||
|
2023
Q2 | $226M | Buy |
|
|||||
|
2023
Q1 | $81.8M | Buy |
|
|||||
|
2022
Q4 | $40.6M | Sell |
|
|||||
|
2022
Q3 | $165M | Sell |
|
|||||
|
2022
Q2 | $280M | Sell |
|
|||||
|
2022
Q1 | $394M | Buy |
|
|||||
|
2021
Q4 | $127M | Sell |
|
|||||
|
2021
Q3 | $655M | Sell |
|
|||||
|
2021
Q2 | $786M | Sell |
|
|||||
|
2021
Q1 | $908M | Buy |
|
|||||
|
2020
Q4 | $36.3M | Sell |
|
|||||
|
2020
Q3 | $525M | Sell |
|
|||||
|
2020
Q2 | $872M | Sell |
|
|||||
|
2020
Q1 | $667M | Buy |
|
|||||
|
2019
Q4 | $105M | Sell |
|
|||||
|
2019
Q3 | $885M | Buy |
|
|||||
|
2019
Q2 | $796M | Buy |
|
|||||
|
2019
Q1 | $545M | Buy |
|
|||||
|
2018
Q4 | $170M | Sell |
|
|||||
|
2018
Q3 | $338M | Buy |
|
|||||
|
2018
Q2 | $296M | Buy |
|
|||||
|
2018
Q1 | $263M | Sell |
|
|||||
|
2017
Q4 | $299M | Sell |
|
|||||
|
2017
Q3 | $347M | Sell |
|
|||||
|
2017
Q2 | $418M | Buy |
|
|||||
|
2017
Q1 | $265M | Buy |
|
|||||
|
2016
Q4 | $131M | Sell |
|
|||||
|
2016
Q3 | $211M | Sell |
|
|||||
|
2016
Q2 | $213M | Buy |
|
|||||
|
2016
Q1 | $121M | Sell |
|
|||||
|
2015
Q4 | $208M | Buy |
|
|||||
|
2015
Q3 | $131M | Sell |
|
|||||
|
2015
Q2 | $316M | Buy |
|
|||||
|
2015
Q1 | $113M | Buy |
|
|||||
|
2014
Q4 | $538K | Buy |
|
|||||
|
2014
Q3 | $444K | Buy |
|
|||||
|
2014
Q2 | $431K | Buy |
|